-
Favipiravir CAS 259793-96-9Favipiravir CAS 259793-96-9, is a broad-spectrum antiviral agent that selectively inhibits the RNA-dependent RNA polymerase (RdRp) of RNA viruses. It is a pyrazinecarboxamide derivative with a...read more
-
Bilastine CAS 202189-78-4Bilastine CAS 202189-78-4, is a second-generation, non-sedating antihistamine belonging to the piperidine derivative class. It is a selective peripheral H₁receptor antagonist used for the...read more
-
Mesalazine CAS 89-57-6Mesalazine CAS 89-57-6, is an anti‑inflammatory drug used for treatment of inflammatory bowel diseases.read more
Indications: ulcerative colitis, Crohn's disease, proctitis, and other inflammatory... -
Tauroursodeoxycholic Acid CAS 14605 22 2Tauroursodeoxycholic Acid CAS 14605-22-2, is a naturally occurring hydrophilic tertiary bile acid, a combination of ursodeoxycholic acid (UDCA) and taurine.read more
Indications: It dissolves... -
Tofacitinib Citrate CAS 540737-29-9Tofacitinib Citrate CAS 540737-29-9, is a Janus kinase (JAK) inhibitor that is administered orally and has immunomodulatory and anti-inflammatory effects. It is a citrate formed by combining...read more
-
Vonoprazan Fumarate CAS 1260141-27-2Vonoprazan Fumarate CAS 1260141-27-2, is a new type of oral potassium-competitive acid blocker that inhibits gastric acid secretion by competitively inhibiting H⁺, K⁺-ATPase (proton pump) in...read more
-
Acalabrutinib CAS 1420477-60-6Acalabrutinib CAS 1420477-60-6, is a highly selective second-generation Bruton's tyrosine kinase (BTK) inhibitor that irreversibly binds to the BTK protein, blocking the B-cell receptor signaling...read more
-
RESMETIROM CAS 920509-32-6RESMETIROM CAS 920509-32-6, is a thyroid hormone receptor beta agonist, treatment of Metabolic Dysfunction Associated Steatotic Liver Disease.read more
-
Sparsentan CAS 254740-64-2Sparsentan CAS 254740-64-2, is a dual endothelin A (ETA) and angiotensin II type 1 (AT1) receptor antagonist, treatment of Immunoglobulin A Nephropathy (IgAN).read more
Feb 07, 2022 · Favipiravir is an antiviral medicine that is used to treat viral infections. Currently it is used in the treatment of Coronavirus disease (COVID-19). Learn about its uses, dosage, side...
Mar 10, 2021 · A favipiravir (a remdesivirhez hasonlóan) a vírus RNS-örökítőanyagának a sokszorozását, magyarul a vírus szaporodását gátolja. A szer egy hamis kódot illeszt be a virális RNS-be, ezzel...
Jun 19, 2020 · Favipiravir 200 mg is the first oral antiviral medication under the trade name FabiFlu for the treatment of mild to severe COVID-19 cases, Glenmark Pharmaceutical launch...
Sep 02, 2020 · Favipiravir (T-705) is a synthetic prodrug, first discovered while assessing the antiviral activity of chemical agents active against the influenza virus in the chemical library of...
Abstract. Favipiravir has been developed as an anti-influenza drug and licensed as an anti-influenza drug in Japan. Additionally, favipiravir is being stockpiled for 2 million people as a...
Favipiravir is one such oral drug that was approved for new and reemerging pandemic influenza in Japan in 2014 and has shown potent in vitro activity against severe acute respiratory...
